Estreno : Impact Factor & More
pISSN: 0097-8663
Share this on:
Key Metrics
SJR 
Q4Literature and Literary Theory
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Estreno Journal Specifications
Indexed in the following public directories
Scopus 
Web of Science
| Overview | |
| Publisher | Ohio Wesleyan University |
| Language | Multi-Language |
| Frequency | Semi-annual |
| General Details | |
| Language | Multi-Language |
| Frequency | Semi-annual |
| Publication Start Year | 1975 |
View less
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in Estreno
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.
- 30 Jun 2026
- Nature cancer
GABA shapes GBM immune responses in a sex-dependent manner.
- 23 Jun 2026
- Nature cancer
GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells.
- 23 Jun 2026
- Nature cancer
The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets.
- 18 Jun 2026
- Nature cancer
Targeting PID1 generates oxysterols to switch macrophage cell fates for improved antitumor immunity.
- 16 Jun 2026
- Nature cancer
Mesenchymal tumor features predict response to immune-checkpoint blockade in glioblastoma.
- 15 Jun 2026
- Nature cancer
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.
- 30 Jun 2026
- Nature cancer
GABA shapes GBM immune responses in a sex-dependent manner.
- 23 Jun 2026
- Nature cancer
GABA signaling activation drives glioblastoma progression in female mice through myeloid-derived suppressor cells.
- 23 Jun 2026
- Nature cancer
The future of tertiary lymphoid structures in cancer immunotherapy as biomarkers and therapeutic targets.
- 18 Jun 2026
- Nature cancer
Targeting PID1 generates oxysterols to switch macrophage cell fates for improved antitumor immunity.
- 16 Jun 2026
- Nature cancer
Mesenchymal tumor features predict response to immune-checkpoint blockade in glioblastoma.
- 15 Jun 2026
- Nature cancer
FAQs on Estreno
How long has Estreno been actively publishing? 
What is the publishing frequency of Estreno?
How many articles did Estreno publish last year?
What is the SJR for Estreno?
Who is the publisher of Estreno?
